• Mashup Score: 6

    Direct oral anticoagulant use has been associated with higher arterial thrombotic events but similar rates of venous thromboembolic events and major bleeding relative to vitamin K antagonist (VKA) use. The findings of a 2022 meta-analysis suggest potential benefits for VKA use in all types of antiphospholipid syndrome (single-positive, double-positive, and triple-positive antibodies). Antiphospholipid syndrome (APS) is an au toimmune disease characterized by venous and arterial thrombotic events. Relativel

    Tweet Tweets with this article
    • DOAC use has been associated w/ higher arterial thrombotic events but similar rates of VTE and major bleeding relative to vitamin K antagonist use. Read an expert analysis to learn more: https://t.co/QpbE9VarsI #Anticoagulants